Effects of cannabidiol on alcohol-related outcomes: A review of preclinical and human research - PubMed (original) (raw)
Review
. 2019 Aug;27(4):359-369.
doi: 10.1037/pha0000272. Epub 2019 May 23.
Affiliations
- PMID: 31120285
- DOI: 10.1037/pha0000272
Review
Effects of cannabidiol on alcohol-related outcomes: A review of preclinical and human research
Christina N Nona et al. Exp Clin Psychopharmacol. 2019 Aug.
Abstract
Increased access to medicinal and recreational cannabis will be accompanied by greater exposure to its chemical constituents, including Δ9-tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD), the primary nonpsychoactive compound. Increasing attention has focused on CBD, in part, due to its potential therapeutic properties. Relatively little is known about how CBD might interact with other commonly used drugs. While a number of studies have explored the influence of cannabis or Δ9-THC on alcohol consumption and treatment outcomes, few have examined the effects of CBD on alcohol-related outcomes. This article reviews preclinical and human studies examining the effects of CBD administration on alcohol responses. Preliminary preclinical results suggest that CBD can attenuate alcohol consumption and potentially protect against certain harmful effects of alcohol, such as liver and brain damage. Also reviewed herein are the few existing studies involving CBD and alcohol coadministration in humans. The paucity of such studies precludes any definitive conclusions relating to CBD-alcohol interactions. Effects of CBD on alcohol use and potential therapeutic implications for alcohol use disorder are discussed. (PsycINFO Database Record (c) 2019 APA, all rights reserved).
Similar articles
- A randomised controlled trial of vaporised Δ9-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute intoxication effects.
Solowij N, Broyd S, Greenwood LM, van Hell H, Martelozzo D, Rueb K, Todd J, Liu Z, Galettis P, Martin J, Murray R, Jones A, Michie PT, Croft R. Solowij N, et al. Eur Arch Psychiatry Clin Neurosci. 2019 Feb;269(1):17-35. doi: 10.1007/s00406-019-00978-2. Epub 2019 Jan 19. Eur Arch Psychiatry Clin Neurosci. 2019. PMID: 30661105 Clinical Trial. - THC and CBD effects on alcohol use among alcohol and cannabis co-users.
Karoly HC, Mueller RL, Andrade CC, Hutchison KE. Karoly HC, et al. Psychol Addict Behav. 2021 Sep;35(6):749-759. doi: 10.1037/adb0000706. Epub 2021 Mar 25. Psychol Addict Behav. 2021. PMID: 33764086 - Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ9-Tetrahydrocannabinol.
Boggs DL, Nguyen JD, Morgenson D, Taffe MA, Ranganathan M. Boggs DL, et al. Neuropsychopharmacology. 2018 Jan;43(1):142-154. doi: 10.1038/npp.2017.209. Epub 2017 Sep 6. Neuropsychopharmacology. 2018. PMID: 28875990 Free PMC article. Review. - An assessment of concurrent cannabidiol and Δ⁹-tetrahydrocannabinol administration in place aversion and taste avoidance conditioning.
Hempel BJ, Clasen MM, Nelson KH, Woloshchuk CJ, Riley AL. Hempel BJ, et al. Exp Clin Psychopharmacol. 2018 Apr;26(2):205-213. doi: 10.1037/pha0000188. Exp Clin Psychopharmacol. 2018. PMID: 29648861 - Does Cannabis Composition Matter? Differential Effects of Delta-9-tetrahydrocannabinol and Cannabidiol on Human Cognition.
Colizzi M, Bhattacharyya S. Colizzi M, et al. Curr Addict Rep. 2017;4(2):62-74. doi: 10.1007/s40429-017-0142-2. Epub 2017 Apr 29. Curr Addict Rep. 2017. PMID: 28580227 Free PMC article. Review.
Cited by
- Cannabidiol or ketamine for preventing the impact of adolescent early drug initiation on voluntary ethanol consumption in adulthood.
Colom-Rocha C, Bis-Humbert C, García-Fuster MJ. Colom-Rocha C, et al. Front Pharmacol. 2024 Aug 27;15:1448170. doi: 10.3389/fphar.2024.1448170. eCollection 2024. Front Pharmacol. 2024. PMID: 39257392 Free PMC article. - Orphan peptide and G protein-coupled receptor signalling in alcohol use disorder.
Anversa RG, Maddern XJ, Lawrence AJ, Walker LC. Anversa RG, et al. Br J Pharmacol. 2024 Mar;181(5):595-609. doi: 10.1111/bph.16301. Epub 2024 Jan 8. Br J Pharmacol. 2024. PMID: 38073127 Free PMC article. Review. - Comparing the Efficacy of Mindfulness-Based Relapse Prevention Versus Relapse Prevention for Alcohol Use Disorder: A Randomized Control Trial.
Skrzynski CJ, Karoly H, Ellingson JM, Hagerty SL, Bryan AD, Hutchison KE. Skrzynski CJ, et al. J Stud Alcohol Drugs. 2023 Jul;84(4):560-569. doi: 10.15288/jsad.21-00392. Epub 2023 Feb 1. J Stud Alcohol Drugs. 2023. PMID: 36971735 Free PMC article. Clinical Trial. - Consuming oral cannabidiol prior to a standard alcohol dose has minimal effect on breath alcohol level and subjective effects of alcohol.
Karoly HC, Drennan ML, Prince MA, Zulic L, Dooley G. Karoly HC, et al. Psychopharmacology (Berl). 2023 May;240(5):1119-1129. doi: 10.1007/s00213-023-06349-z. Epub 2023 Mar 20. Psychopharmacology (Berl). 2023. PMID: 36939855 Free PMC article. - Alcohol & cannabinoid co-use: Implications for impaired fetal brain development following gestational exposure.
Rouzer SK, Gutierrez J, Larin KV, Miranda RC. Rouzer SK, et al. Exp Neurol. 2023 Mar;361:114318. doi: 10.1016/j.expneurol.2023.114318. Epub 2023 Jan 7. Exp Neurol. 2023. PMID: 36627039 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources